Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 08, 2026
Onyx Scientific will invest more than £1.5 million, or about $2 million, to expand commercial active pharmaceutical ingredient manufacturing capacity at its Sunderland, United Kingdom, facility.
read more
Onyx Scientific has made a strategic investment to position the company for a commercial API license.
read more
Tuesday, September 29, 2026
Ontario is providing C$1.75 million through its Life Sciences Scale-Up Fund to support upgrades at Piramal Pharma Solutions’ drug substance facility in Aurora. Piramal plans to invest C$5.31 million in the site project.
read more
Wednesday, September 09, 2015
The Ontario Government, University of Toronto, and MaRS Discovery District (MaRS) have announced a collaboration with Janssen Inc. to launch the successful Johnson & Johnson Innovation, JLABS incubator model in Toronto.
read more
Tuesday, January 26, 2016
Medidata a global provider of cloud-based solutions for clinical research in life sciences, announced that ONO Pharmaceutical Co., Ltd. (“ONO”) has expanded its adoption of the Medidata Clinical Cloud® to include all clinical trials testing the use ...
read more
OnKure entered into an exclusive license and option agreement with KDAc Therapeutics to support the continued development of KDAc’s selective histone deacetylase 3 (HDAC3) inhibitor program.
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Wednesday, September 18, 2019
One Drop announced $40 million in Series B financing, led by pharmaceutical company, Bayer.
read more
Wednesday, December 12, 2018
OnDosis and Recipharm have entered into an agreement for the formulation development of an ADHD treatment for the US market.
read more
Wednesday, September 30, 2026
OnDosis has selected Adare Pharma Solutions to provide development and manufacturing services for Imfocy, its lead U.S. program for attention-deficit/hyperactivity disorder.
read more
Oncternal Therapeutics announced a clinical supply arrangement with Pharmacyclics.
read more
OncoZenge AB has engaged Meribel Pharma Solutions (formerly Recipharm) as its Contract Development and Manufacturing Organization (CDMO) for the BupiZenge™ Phase 3 Project.
read more
OncoTEX Inc and Sterling Pharma Solutions announced the signing of a clinical development agreement for the manufacture of OncoTex’s novel platinum-resistant oncology drug candidate, OxaliTEX.
read more
OncoSec has entered into a research collaboration agreement with the University of California, Los Angeles on behalf of Roger S. Lo, M.D., Ph.D. and his research team
read more
Wednesday, January 06, 2021
Oncorus has signed a 15-year lease to build an 88,000 square foot GMP viral immunotherapy clinical manufacturing facility in Andover, Massachusetts.
read more